FENACLON

ClCCC(=O)NCCC1=CC=CC=C1

InChIKey=BITWVVLBVUMFHU-UHFFFAOYSA-N

InChI=1S/C11H14ClNO/c12-8-6-11(14)13-9-7-10-4-2-1-3-5-10/h1-5H,6-9H2,(H,13,14)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Fenaclon is an anticonvulsant. It was developed in the former USSR. It is indicated for the treatment of epilepsy.

Targets

Primary Target	Pharmacology	Condition	Potency
acetylcholine metabolic process 11 Target ID: GO:0008291 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5599516	Modulator 828

Conditions

Condition	Modality	Targets	Highest Phase	Product
Epilepsy 121 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5748835 https://www.ncbi.nlm.nih.gov/pubmed/14303595 https://www.ncbi.nlm.nih.gov/pubmed/14245997	Primary		Approved 8429	Phenacon Approved Use Fenaclon is indicated for the treatment of epilepsy. Launch Date -3.86639987E11

PubMed

Title	Date	PubMed
[THE ANTIEPILEPTIC PREPARATION PHENACON].	1964 Oct	14303595
[Effect of phenacon on the content of potassium and sodium ions and of acetylcholine in the brain].	1965 Jan-Feb	5845035
[Effect of phenacon on the content of acetylcholine and the activity of cholinesterase in the brain in electroshock].	1967 Mar-Apr	5599516

Patents

In Vivo Use Guide

1-2 g after the meal, 2–5 g per day

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:40:02 UTC 2023` Edited by `admin` on `Fri Dec 15 15:40:02 UTC 2023`
Record UNII	6M4IR9QY13
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

FENACLON

Official Name

English

3-CHLORO-N-PHENETHYLPROPIONAMIDE

Systematic Name

English

fenaclon [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C264